2025 Taipei Cycle Show: CHC Drives Innovation in Sustainability and Common Protocol for Green Transportation
Taipei Cycle Show highlighted Taiwan's advancements in sustainable cycling under the theme "Green Forward," aligning with ...
PharmiWeb4h
Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer
AstraZeneca’s Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Le Lézard2h
IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer
AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
Independent Newspaper Nigeria on MSN18h
A Decade Of Progress: Strategic Interventions Slash Nigeria’s Tuberculosis Mortality
In Nigeria’s teeming urban centers and far-flung villages, tuberculosis (TB) persists as a quiet scourge, claiming lives with a stealth that belies its lethality.Often overshadowed by flashier health ...
Plasteurope.com10hOpinion
A Fresh Start in Amsterdam: What the European Recycling Industry Hopes to Gain from PRSE
When the European recycling industry gathers at the Plastics Recycling Show Europe (PRSE) in Amsterdam starting 1 April, the ...
EMBO Press3h
Mouse promoters are characterised by low occupancy and high turnover of RNA polymerase II
Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...
EMBO Press3h
Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
Liver TET1 was found to promote metabolic dysfunction-associated steatotic liver disease (MASLD) by regulating CD36 ...